津膜科技 reported revenue of ¥0.17B for the period ended 2026-06-30, +61.9% year on year. Net income was ¥-0.01B, a -4.3% net margin on a 22.4% gross margin. Free cash flow for the period was ¥-0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.17B | +61.9% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -963.7% |
| Gross margin | 22.4% | Net margin -4.3% |
| Revenue Q/Q | -6.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.13B | 77.6% |
| R&D | ¥0.01B | 7.7% |
| SG&A | ¥0.03B | 17.3% |
| Tax & other | ¥0.00B | 0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥1.08B |
| Total liabilities | ¥0.48B |
| Shareholders' equity | ¥0.60B |
| Equity / assets | 55.3% |
| Operating cash flow | ¥-0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.02B |
| Cash conversion (OCF / net income) | 208% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
迪森股份 ・ 银邦股份 ・ *ST开元 ・ 润和软件 ・ 科恒股份 ・ 麦克奥迪 ・ 天银机电 ・ 联创股份 ・ 华民股份 ・ 南大光电 ・ 泰格医药 ・ 长亮科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies